CHARGE, which affects 1 in 10,000 babies, is an acronym whose letters stand for some of the more common symptoms of the condition: coloboma of the eye, heart defects, atresia of the choanae, retardation of growth and/or development, genital and/or urinary abnormalities, and ear abnormalities and deafness.
Originally, the researchers were examining the tumor-suppressive properties of the protein, called p53, not investigating developmental disorders. But when a mouse model developed a strange set of deficiencies, the researchers followed a trail of clues that led them to link p53 with CHARGE syndrome.
"It was a very big surprise and very intriguing," said Jeanine Van Nostrand, PhD, lead author of a paper describing the research and a former Stanford graduate student, now at The Salk Institute for Biological Studies. "P53 had never before been shown to have a role in CHARGE."
The paper will be published online Aug. 3 in Nature. The senior author is Laura Attardi, PhD, professor of radiation oncology and of genetics.
Cellular quality control regulator
The researchers originally created a mouse model that expressed a mutated form of the protein, known as p53, to investigate the behavior of p53 in suppressing tumors. Mice expressing only the mutated protein survived. But to their surprise, heterozygous mice, or those with one copy of the mutated p53 and one normal copy, developed symptoms of CHARGE and died in utero.
P53 is a cellular quality-control regulator. When it spots an ailing cell, it triggers other proteins to kill the cell or arrest its division. In a developing human or mouse, other proteins switch off p53 so it doesn't inadvertently kill important cells. The mutated form of p53 created by the researchers had a disabled off-switch, but it also couldn't communicate with other proteins to spark the cellular death. Therefore, a mouse containing only the mutated p53 survived to adulthood.
But when mice had one copy of a mutated p53 gene and one normal copy, the resultant proteins formed hybrids. These hybrid p53 proteins couldn't be turned off, but they retained the ability to trigger cellular death. Interestingly, these proteins only affected certain types of cells, causing the symptoms of CHARGE. The results suggest that p53 may play a role in other developmental disorders, Attardi said.
"It really reiterates how carefully p53 must be regulated," Attardi said. "It needs to be turned on at the right time and place. If it's not, it can cause damage."
CHARGE linked to gene mutation
The mechanisms of CHARGE syndrome remain a mystery, although it has been linked to a mutation in a gene called CHD7. Attardi's team examined the connection between p53 and CHD7. They discovered that the CHD7 protein can keep p53 turned off.
By linking p53 with CHARGE, this study elucidates molecular pathways that could be used to develop CHARGE therapies, said co-author Donna Martin, MD, PhD, associate professor of pediatrics and of human genetics at the University of Michigan Medical School and an expert on CHARGE.
Additional Stanford authors are former graduate students Colleen Brady, PhD, and Thomas Johnson, MD; postdoctoral scholar Heiyoun Jung, PhD; graduate students Daniel Fuentes, Chieh-Yu Lin and Chien-Jung Lin; Margaret Kozak, a former research assistant; Hannes Vogel, MD, professor of pathology and of pediatrics; Jonathan Bernstein, MD, assistant professor of pediatrics; and Joanna Wysocka, PhD, associate professor of chemical and systems biology and of developmental biology.
Other authors of the study are affiliated with Hôpital Necker-Enfants Malades in Paris, Université Paris Descartes, the Indiana University School of Medicine and the University of Michigan Medical School.
The study was supported by the National Science Foundation; the National Cancer Institute (grant 1F31CA167917); the National Institutes of Health (grants R01GM095555, R01DC009410, HL118087, HL121197 and R01CA140875); the American Heart Association; the March of Dimes Foundation; the American Cancer Society; and the Leukemia & Lymphoma Society.
Information about the Stanford's Department of Radiation Oncology and the Department of Genetics, which also supported the study, is available at http://radonc.stanford.edu and http://genetics.stanford.edu.
The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit http://mednews.stanford.edu. The medical school is part of Stanford Medicine, which includes Stanford Hospital & Clinics and Lucile Packard Children's Hospital Stanford. For information about all three, please visit http://stanfordmedicine.org/about/news.html.
Print media contact: Rosanne Spector at (650) 725-5374 (firstname.lastname@example.org)
Broadcast media contact: M.A. Malone at (650) 723-6912 (email@example.com)
Rosanne Spector | Eurek Alert!
Tiny songbird discovered to migrate non-stop, 1,500 miles over the Atlantic
01.04.2015 | University of Massachusetts at Amherst
The 'intraterrestrials': New viruses discovered in ocean depths
01.04.2015 | National Science Foundation
Spring is here and ectotherms, or animals dependent on external sources to raise their body temperature, are becoming more active. Recent studies have shown...
Glass-fronted office buildings are some of the biggest energy consumers, and regulating their temperature is a big job. Now a façade element developed by Fraunhofer researchers and designers for glass fronts is to reduce energy consumption by harnessing solar thermal energy. A demonstrator version will be on display at Hannover Messe.
In Germany, buildings account for almost 40 percent of all energy usage. Heating, cooling and ventilating homes, offices and public spaces is expensive – and...
Outstanding chemical, thermal and tribological properties predestine silicon carbide for the production of ceramic components of high volume. A novel method now overcomes the procedural and technical limitations of conventional design methods for the production of components with large differences in wall thickness and demanding undercuts.
Extremely hard as diamond, shrinking-free manufacturing, resistance to chemicals, wear and temperatures up to 1300 °C: Silicon carbide (SiSiC) bundles all...
In an experiment at the Department of Energy's SLAC National Accelerator Laboratory, scientists precisely measured the temperature and structure of aluminum as...
The IPH presents a solution at HANNOVER MESSE 2015 to make ship traffic more reliable while decreasing the maintenance costs at the same time. In cooperation with project partners, the research institute from Hannover, Germany, has developed a sensor system which continuously monitors the condition of the marine gearbox, thus preventing breakdowns. Special feature: the monitoring system works wirelessly and energy-autonomously. The required electrical power is generated where it is needed – directly at the sensor.
As well as cars need to be certified regularly (in Germany by the TÜV – Technical Inspection Association), ships need to be inspected – if the powertrain stops...
25.03.2015 | Event News
19.03.2015 | Event News
17.03.2015 | Event News
01.04.2015 | Earth Sciences
01.04.2015 | Information Technology
01.04.2015 | Physics and Astronomy